New Market Study: "Foundation for Innovative New Diagnostics - Product Pipeline Analysis"
Foundation for Innovative New Diagnostics (FIND) is a pharmaceutical and healthcare company, based in Switzerland. The company develops and implements diagnostic tools for poverty related diseases. It focuses mainly on tuberculosis, malaria, human African trypanosomiasis and other neglected diseases. The company supports the research and development of promising reagents or platforms and oversees their evaluation and demonstration in both laboratory and field trials. Its diseases and projects are tuberculosis, human African trypanosomiasis, leishmaniasis, malaria, and collecting evidence and scaling up....
View full press release